Grand Pharmaceutical Group Limited

HK$4.45As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0512Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 13.36%
Div yield 3.80%
ROE 6.40%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.71
PE TTM 14.05
TSR TTM (44.26%)
Mkt cap HK$15.58B
ROIC 6.72%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.11
14.87%
4.00%
Hold 5|11|1|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.05
0.05
0.05
9.67%
15.56%
15.76%
12.12%
Revenue$M
893.1
894.3
889.5
879.1
6.99%
2.18%
2.32%
3.59%
Peers (US$1.988B)
Cap (US$)
PE
1.993B
19.36x
Capital
TTM
5Y
10Y
Leveragex
14.35
(0.662)
(0.546)
EBIT/Intx
0.077
0.240
0.310
Own earn%
(49.15)
234.25
170.72
Sh yield%
34.11
40.72
39.57
Owners
Insiders/Inst%
8.39
37.65
Short interest%
4.01
SBC / revenue%
1.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
32–41
$1 testx
−0.2
Incr. ROIC%
6